Showing results (121-130 of 761) with videos related to

Sort By:
Pageof 77
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1997
Differential regulation of angiotensin peptides in plasma and kidney: effects of adrenalectomy and estrogen treatmentD J Campbell
The New Zealand Dental Journal|December 1, 1995
A brief history of dental radiographyD J Campbell
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1994
Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver diseaseA A Nanji, S Khwaja, S R Tahan, et al.
Free Radical Biology & Medicine|June 2, 1998
Free radical formation during ketamine anesthesia in rats: a cautionary noteL A Reinke, Y Kotake, D R Moore, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Protective effects of a novel quinone derivative, (2E)-3-[5-(2,3 dimethoxy-6-methyl-1,4-benzoquinoyl)]-2-nonyl-2-propanoic acid on experimental alcoholic liver injuryA A Nanji, S M Sadrzadeh, U Khettry, et al.
Journal of Clinical Gastroenterology|October 1, 1985
Hepatorenal syndrome associated with obstructive jaundiceA A Nanji, C H Scudamore, J D Filipenko, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 12, 2001
Downregulation of nuclear sex steroid receptor activity correlates with severity of alcoholic liver injuryP K Eagon, M S Elm, S D Tadic, et al.
Hepatology (Baltimore, Md.)|September 26, 1997
Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver diseaseC J Li, A A Nanji, A N Siakotos, et al.
Experimental and Molecular Pathology|February 1, 1995
Intercellular adhesion molecule-1 expression in experimental alcoholic liver disease: relationship to endotoxemia and TNF alpha messenger RNAA A Nanji, B Griniuviene, L K Yacoub, et al.
Pageof 77